ADHERENCE AND PERSISTENCE IN PATIENTS INITIATING TREATMENT WITH INJECTABLE THERAPIES FOR TYPE 2 DIABETES MELLITUS (T2DM) IN SPAIN

被引：1
|
作者：
Sicras-Mainar, A. [1 ]
Navarro, R. [2 ]
Ruiz, L. [3 ]
Morano, R. [3 ]
机构：
[1] Badalona Serv Assistencials, Barcelona, Spain
[2] Hosp Badalona Germans Trias & Pujol, Barcelona, Spain
[3] GlaxoSmithKline, Madrid, Spain
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.2122
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PDB82
引用
收藏
页码：A612 / A612
页数：1
相关论文
共 50 条
  • [21] MobiDiabet: Mobile Telemonitoring System for Patients with Type 2 Diabetes Mellitus (T2DM)
    Alcala Juarez, Anakaren
    Hernandez Villegas, Manuel Alejandro
    Dominguez, Eduardo Lopez
    Hernandez Velazquez, Yesenia
    Dominguez Isidro, Saul
    Ovando Diego, Liliana
    Hernandez Sanchez, Olivia
    De La Calleja, Jorge
    Pomares Hernandez, Saul Eduardo
    Medina Nieto, Maria Auxilio
    [J]. APPLIED SCIENCES-BASEL, 2020, 10 (22): : 1 - 36
  • [22] Development and Validation of Yoga Program for Patients with Type 2 Diabetes Mellitus (T2DM)
    Thulasi, Arun
    Kumar, Vinod
    Jagannathan, Aarti
    Angadi, Praveen
    Umamaheswar, Kundapur
    Raghuram, Nagarathna
    [J]. JOURNAL OF RELIGION & HEALTH, 2022, 61 (03): : 1951 - 1965
  • [23] Association between Hypoglycemia and Medication Adherence among Veterans With Type 2 Diabetes Mellitus (T2DM)
    Zhao, Yingnan
    Campbell, Claudia
    Fonseca, Vivian
    Shi, Lizheng
    [J]. DIABETES, 2012, 61 : A553 - A553
  • [24] REAL-WORLD COMPARATIVE EFFECTIVENESS ANALYSIS OF PATIENTS INITIATING INJECTABLE TREATMENTS FOR TYPE 2 DIABETES MELLITUS (T2DM): PILOT DATA FROM THE INITIATOR STUDY
    Grabner, M.
    Wei, W.
    Raparla, S.
    Quimbo, R. A.
    Cziraky, M. J.
    Thayer, S. W.
    Brekke, L.
    Buysman, E.
    Crown, W.
    Hu, W.
    Cuddihy, R.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A494 - A494
  • [25] Development and Validation of Yoga Program for Patients with Type 2 Diabetes Mellitus (T2DM)
    Arun Thulasi
    Vinod Kumar
    Aarti Jagannathan
    Praveen Angadi
    Kundapur Umamaheswar
    Nagarathna Raghuram
    [J]. Journal of Religion and Health, 2022, 61 : 1951 - 1965
  • [26] Empagliflozin in Patients With Type 2 Diabetes Mellitus (T2DM) and Renal Impairment (RI)
    Barnett, Anthony H.
    Mithal, Ambrish
    Manassie, Jenny
    Jones, Russell
    Rattunde, Henning
    Woerle, Hans J.
    Broedl, Uli C.
    [J]. DIABETES, 2013, 62 : A286 - A286
  • [27] Achievement of Diabetes-related Treatment Goals with Canagliflozin (CANA) in Patients with Type 2 Diabetes Mellitus (T2DM)
    Blonde, Lawrence
    Woo, Vincent
    Mathieu, Chantal
    Yee, Jacqueline
    Vijapurkar, Ujjwala
    Meininger, Gary
    [J]. DIABETES, 2014, 63 : A284 - A284
  • [28] HDL EFFLUX CAPACITY, AND PARTICLE REMODELLING IN PATIENTS WITH TYPE 1 DIABETES MELLITUS (T1DM) AND TYPE 2 DIABETES MELLITUS (T2DM)
    Byrne, R.
    Curley, S.
    Ahmed, K.
    Ahmed, M.
    Gibney, J.
    Mcgillicuddy, F.
    [J]. ATHEROSCLEROSIS, 2020, 315 : E65 - E66
  • [29] THE PREVALENCE OF MICROALBUMINURIA IN CHILDREN WITH TYPE 2 DIABETES MELLITUS (T2DM)
    Yafi, Michael
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2019, 104 : A250 - A250
  • [30] Regional effects of type 2 diabetes mellitus (T2DM) on neurodegeneration
    Moran, C.
    Phan, T. G.
    Beare, R. J.
    Chen, J.
    Blizzard, L.
    Venn, A.
    Greenaway, T.
    Munch, G.
    Forbes, J.
    Pearson, S.
    Srikanth, V
    [J]. INTERNATIONAL JOURNAL OF STROKE, 2012, 7 : 20 - 20
12345